Navigation Links
Woman gets cancer from transplanted kidney

For a person with failing kidneys, receiving a transplanted kidney can be a lifesaver. But in rare cases, the transplanted organ may pass on cancer to the recipient. Wisconsin researchers report that a transplant recipient whose donor had previously had lung cancer developed cancer herself several years after her transplant. //

The woman has made a full recovery, but her case underscores the importance of closely following patients after organ transplantation, according to researchers led by Dr. Sigurdur Bodvarsson of the University of Wisconsin-Madison.

Analysis of the cancer cells and the patient's normal tissue indicated that the cancer had its start in the donated organ. The relative who had donated the kidney had been diagnosed with small cell carcinoma of the lung nearly 2 years before donating a kidney.

People who receive an organ transplant are known to have an increased risk of several types of cancer, including Kaposi sarcoma, non-Hodgkin lymphoma and non-melanoma skin cancers. The inability to fight off cancer-causing viruses due to a suppressed immune system as well as the effects of anti-rejection drugs are thought to account for some of this increased cancer risk.


'"/>




Page: 1

Related medicine news :

1. Woman prisoner in Bihar found HIV positive
2. Death Of Singaporean Woman After Mysterious Illness
3. Woman In Coma Gives Birth To Daughter
4. Another British Woman In Court For New Breast Cancer Drug
5. Woman swallows mobile phone - assault by boyfriend?
6. Death Of Woman Following Family Planning Operation Creates Panic
7. Life Beyond Cancer - Delhi Woman Tells How
8. UK Woman To Raise Funds For Women Welfare
9. Initial tests negative for bird flu in Romanian Woman
10. Woman suffering from degenerative disorder committed assisted suicide
11. Woman Tests Negative For Japanese Encephalitis: Health Minister
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: